A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced Hepatocellular Carcinoma with the DEB-TACE (drug-loaded Microsphere Transcatheter Arterial Chemoembolization) Combined with Hepatic Artery Perfusion of Raltitrexed and Oxaliplatin (SALOX-HAIC) Regimen
Latest Information Update: 20 Feb 2025
At a glance
- Drugs Camrelizumab (Primary) ; Oxaliplatin (Primary) ; Raltitrexed (Primary) ; Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 20 Feb 2025 New trial record